The future of antisense therapy: combination with anticancer treatments.
about
Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer.Combined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cellsGold Nanorods Bioconjugates for Intracellular Delivery and Cancer Cell Apoptosis.Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides.Time depended Bcl-2 inhibition might be useful for a targeted drug therapy.BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.Antisense-based cancer therapeutics: are we there yet?The triple helix: 50 years later, the outcome.Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines.In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with α-tocopherol succinate.The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells.Comparison of strategies targeting Raf-1 mRNA in ovarian cancer.UTRN on chromosome 6q24 is mutated in multiple tumors.Ki67 targeted strategies for cancer therapy.The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.Antimicrobial synergy between mRNA- and protein-level inhibitors.
P2860
Q31142003-84836BB9-771E-4170-94CC-5626AF3AB636Q34732127-C990BC6B-CB4E-460F-BFA6-AC1F21FC2290Q35580865-BE52FB98-CE22-4F27-9157-7E8879571D5AQ35609317-18473020-437A-463A-9A1A-2B872B38ECE9Q36243019-E9555FF9-05B2-4470-ABA6-B85841CBA1FFQ36419013-D61ADB26-DCDA-4199-BB83-6140AFF778D5Q36458427-59F8E1B5-8DC8-4825-9518-1DF7E6E3C9A3Q36868459-4F28C6B0-4E76-42C9-9AD5-5B03F4FE7EBDQ37641982-3EA9D104-37B0-4DEB-8631-543FA88CD2B1Q38697575-FB2B536B-FD13-4F99-9E91-619F1A73AFB2Q39212627-ED9C0386-704E-43CB-878A-5EB11490CDADQ40368977-20D308CC-69A9-403F-9F07-A821EAC56D9EQ42829867-32EDBBB6-0F23-46B6-A966-CD6C6B9FC3A5Q45873470-32706EA9-D678-4701-8A4E-783536AB05E2Q48382639-07C60839-BADA-4B71-9522-C26AC10825C4Q54485697-7F7A7DAA-D6A9-4CA9-80FD-FE3679B4C3B9
P2860
The future of antisense therapy: combination with anticancer treatments.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The future of antisense therapy: combination with anticancer treatments.
@ast
The future of antisense therapy: combination with anticancer treatments.
@en
type
label
The future of antisense therapy: combination with anticancer treatments.
@ast
The future of antisense therapy: combination with anticancer treatments.
@en
prefLabel
The future of antisense therapy: combination with anticancer treatments.
@ast
The future of antisense therapy: combination with anticancer treatments.
@en
P2860
P356
P1433
P1476
The future of antisense therapy: combination with anticancer treatments.
@en
P2093
Annamaria Biroccio
Gabriella Zupi
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206812
P407
P577
2003-09-01T00:00:00Z